Clinical Trial Update: Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy [NA]

View source ↗

Summary

Clinical trial investigating the effect of a neutrophil elastase inhibitor on lung injury after esophagectomy in esophageal cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Neutrophil Elastase Inhibitor (neutrophil elastase inhibitor)

Snippet

Sponsor: Yokohama City University Medical Center | Conditions: Esophageal Cancer | NA | Status: COMPLETED